Cammisotto, V.; Pastori, D.; Nocella, C.; Bartimoccia, S.; Castellani, V.; Marchese, C.; Sili Scavalli, A.; Ettorre, E.; Viceconte, N.; Violi, F.;
et al. PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation. Antioxidants 2020, 9, 296.
https://doi.org/10.3390/antiox9040296
AMA Style
Cammisotto V, Pastori D, Nocella C, Bartimoccia S, Castellani V, Marchese C, Sili Scavalli A, Ettorre E, Viceconte N, Violi F,
et al. PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation. Antioxidants. 2020; 9(4):296.
https://doi.org/10.3390/antiox9040296
Chicago/Turabian Style
Cammisotto, Vittoria, Daniele Pastori, Cristina Nocella, Simona Bartimoccia, Valentina Castellani, Cinzia Marchese, Antonio Sili Scavalli, Evaristo Ettorre, Nicola Viceconte, Francesco Violi,
and et al. 2020. "PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation" Antioxidants 9, no. 4: 296.
https://doi.org/10.3390/antiox9040296
APA Style
Cammisotto, V., Pastori, D., Nocella, C., Bartimoccia, S., Castellani, V., Marchese, C., Sili Scavalli, A., Ettorre, E., Viceconte, N., Violi, F., Pignatelli, P., & Carnevale, R.
(2020). PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation. Antioxidants, 9(4), 296.
https://doi.org/10.3390/antiox9040296